The drug chapter segment of the Allergic Contact Dermatitis Market report encloses the detailed analysis of Allergic Contact Dermatitis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Allergic Contact Dermatitis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.